123 related articles for article (PubMed ID: 36123865)
1. Effect of postmastectomy radiotherapy on pT1-2N1 breast cancer patients with different molecular subtypes: A real-world study based on the inverse probability of treatment weighting method.
Ye S; Hu W
Medicine (Baltimore); 2022 Sep; 101(37):e30610. PubMed ID: 36123865
[TBL] [Abstract][Full Text] [Related]
2. The survival benefit of postmastectomy radiotherapy for breast cancer patients with T1-2N1 disease according to molecular subtype.
Wei J; Jiang Y; Shao Z
Breast; 2020 Jun; 51():40-49. PubMed ID: 32200207
[TBL] [Abstract][Full Text] [Related]
3. Effect of postmastectomy radiotherapy on pT
Guo XY; Sun GY; Wang HM; Liu M; Zhang YJ; Zhang N; Tang Y; Zhao XR; Jing H; Fang H; Wen G; Guo QS; Wu HF; Wang XH; Ma CY; Li YX; Cheng J; Shi M; Wang SL
Breast; 2022 Feb; 61():108-117. PubMed ID: 34942430
[TBL] [Abstract][Full Text] [Related]
4. T1-2N1M0 triple-negative breast cancer patients from the SEER database showed potential benefit from post-mastectomy radiotherapy.
Wang X; Xu Y; Guo S; Zhang J; Abe M; Tan H; Wang S; Chen P; Zong L
Oncol Lett; 2020 Jan; 19(1):735-744. PubMed ID: 31897189
[TBL] [Abstract][Full Text] [Related]
5. Effect of postmastectomy radiotherapy on T1-2N1M0 triple-negative breast cancer.
Xia LY; Xu WY; Zhao Y
PLoS One; 2022; 17(6):e0270528. PubMed ID: 35749525
[TBL] [Abstract][Full Text] [Related]
6. The prognostic differences and the effect of postmastectomy radiotherapy between post-chemotherapy ypT1-2ypN1 and de novo pT1-2N1 breast cancer.
Yang T; Zhong X; Wang J; Xiang Z; Zeng Y; Yu S; Dai Z; Xu N; Luo T; Liu L
Cancer Med; 2023 Apr; 12(7):8112-8121. PubMed ID: 36734308
[TBL] [Abstract][Full Text] [Related]
7. Development and validation of nomograms for predicting survival outcomes in patients with T1-2N1 breast cancer to identify those who could not benefit from postmastectomy radiotherapy.
Pu H; Luo Y; Zhang L; Li X; Li F; Chen J; Qian S; Tang Y; Zhao X; Hou L; Gao Y
Front Oncol; 2023; 13():1112687. PubMed ID: 37056328
[TBL] [Abstract][Full Text] [Related]
8. The effect of postmastectomy radiotherapy in node-positive triple-negative breast cancer.
Zhang L; Tang R; Deng JP; Zhang WW; Lin HX; Wu SG; He ZY
BMC Cancer; 2020 Nov; 20(1):1146. PubMed ID: 33238939
[TBL] [Abstract][Full Text] [Related]
9. Biological subtype predicts locoregional recurrence after postmastectomy radiotherapy in Chinese breast cancer patients.
Wang J; Luo J; Jin K; Wang X; Yang Z; Ma J; Mei X; Wang X; Zhou Z; Yu X; Chen X; Guo X
Cancer Med; 2020 Apr; 9(7):2427-2434. PubMed ID: 32048817
[TBL] [Abstract][Full Text] [Related]
10. The trade-off of post-mastectomy radiotherapy usage for the breast cancer patients aged 70 years or older: a study based on SEER database.
Lin J; Luo S; Zhang J; Song C
BMC Geriatr; 2023 Oct; 23(1):625. PubMed ID: 37803254
[TBL] [Abstract][Full Text] [Related]
11. Association of molecular subtypes and treatment with survival in invasive micropapillary breast cancer: an analysis of the Surveillance, Epidemiology, and End Results database.
Tang Z; Li L; Huang X; Zhao Y; Huang L
Breast Cancer; 2024 Mar; 31(2):205-216. PubMed ID: 38043116
[TBL] [Abstract][Full Text] [Related]
12. Benefits of post-mastectomy radiation for T4N0M0 breast cancer patients: A SEER Database study.
Zhao R; He W; Guan X
Cancer Treat Res Commun; 2022; 32():100586. PubMed ID: 35691256
[TBL] [Abstract][Full Text] [Related]
13. Practical Model to Optimize the Strategy of Adjuvant Postmastectomy Radiotherapy in T1-2N1 Breast Cancer With Modern Systemic Therapy.
Xu FF; Cao L; Xu C; Cai G; Wang SB; Qi WX; Chen JY
Front Oncol; 2022; 12():789198. PubMed ID: 35280719
[TBL] [Abstract][Full Text] [Related]
14. Postmastectomy radiotherapy in patients with T
Luo M; Jin Y; Xu C; Chen H; Zhang K; Chen Q; Jin C; Lu J; Wang J; Huang J; Deng H; Jin W; Zheng S; Chen Y; Zhou J
J Cancer Res Clin Oncol; 2023 Sep; 149(12):9979-9990. PubMed ID: 37256383
[TBL] [Abstract][Full Text] [Related]
15. [Risk-adapted postmastectomy radiotherapy based on local-regional recurrence for T1-2N1M0 breast Cancer].
Li M; Wang SL; Fang H; Tang Y; Chen B; Qi SN; Song YW; Liu YP; Lu NN; Li N; Tang Y; Ren H; Jin J; Li YX
Zhonghua Zhong Liu Za Zhi; 2017 Nov; 39(11):841-849. PubMed ID: 29151291
[No Abstract] [Full Text] [Related]
16. [Clinical features and prognosis of patients with first-episode liver metastasis of different molecular subtypes of breast cancer].
Wu SY; Tan Y; Guan YS
Zhonghua Gan Zang Bing Za Zhi; 2016 Jun; 24(6):422-8. PubMed ID: 27465945
[TBL] [Abstract][Full Text] [Related]
17. Survival following radiotherapy in young women with localized early-stage breast cancer according to molecular subtypes.
Liu QQ; Sun HF; Yang XL; Chen MT; Liu Y; Zhao Y; Zhao YY; Jin W
Cancer Med; 2019 Jun; 8(6):2840-2857. PubMed ID: 31016890
[TBL] [Abstract][Full Text] [Related]
18. Impact of molecular subtype on locoregional recurrence in mastectomy patients with T1-T2 breast cancer and 1-3 positive lymph nodes.
Moo TA; McMillan R; Lee M; Stempel M; Ho A; Patil S; El-Tamer M
Ann Surg Oncol; 2014 May; 21(5):1569-74. PubMed ID: 24488216
[TBL] [Abstract][Full Text] [Related]
19. Postmastectomy radiation therapy can improve survival for breast cancer patients with 1-3 positive axillary lymph nodes: a retrospective cohort study using the SEER database.
Yang J; Zhang X; Ye Y; Lin Y; Yang Q; Cai H
Transl Cancer Res; 2021 May; 10(5):1984-2001. PubMed ID: 35116521
[TBL] [Abstract][Full Text] [Related]
20. Biological Subtype Predicts Risk of Locoregional Recurrence After Mastectomy and Impact of Postmastectomy Radiation in a Large National Database.
Tseng YD; Uno H; Hughes ME; Niland JC; Wong YN; Theriault R; Blitzblau RC; Moy B; Breslin T; Edge SB; Hassett MJ; Punglia RS
Int J Radiat Oncol Biol Phys; 2015 Nov; 93(3):622-30. PubMed ID: 26461004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]